Profile of Brazilian inpatients with Covid-19 vaccine breakthrough infection and risk factors for unfavorable outcome

Datos Bibliográficos

ID14968698
AutoresMatheus A S de Jesus (Federal University of São João del-Rei, autor de correspondencia), Natália Satchiko Hojo-Souza (0000-0002-3308-5149, Fundação Oswaldo Cruz), Thiago R Moraes, Thiago R de Moraes (Federal University of São João del-Rei), Daniel L Guidoni (0000-0002-1953-9132, Universidade Federal de Ouro Preto), Fernanda Sumika Hojo de Souza (0000-0003-1432-1967, Universidade Federal de Ouro Preto)
Año2022
Volumen46
Páginas1-10
Fecha de publicación2022-01-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaRevista Panamericana de Salud Pública (JOURNAL)
Identificadores de la revistaISSN: 1020-4989 • E-ISSN: 1680-5348
EditorialPan American Health Organization (PUBLISHER • US)
DOI10.26633/rpsp.2022.106
PMID36016834
OpenAlexW4292621952
IdiomaEN
Citas recibidas2
Referencias citadas3

We characterized the profile of hospitalized Brazilian patients with COVID-19 vaccine breakthrough infection and the risk factors for an unfavorable outcome. These data allow to identify priority groups to receive a booster dose and to continue using personal protection

Booster dose · Case fatality rate · Immune system · Immunization · Influenza vaccine · Intensive care medicine · Vaccination · Vaccination schedule · COVID-19 Clinical Research Studies · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Emergency Medicine · Epidemiology · Immunology · Internal Medicine · Pediatrics

Herramientas

Abrir DOIOpen Access